ReviewInternational journal of transgender health2026
Rapid systematic literature review of endometriosis in transgender, gender diverse and non-binary individuals: Barriers, treatment, and lived experiences.
Review in International journal of transgender health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: It is anticipated that endometriosis, a chronic inflammatory condition affecting around 10% of people assigned female at birth (AFAB), is significantly underreported within transgender, gender diverse, and non-binary (TGDN) people due to specific barriers this population experiences in gaining access to supportive, gender-affirming healthcare. This rapid systematic literature review (RSLR) aims to explore existing research on the management, treatment, and lived experiences of endometriosis and associated pelvic pain among TGDN individuals AFAB, to ultimately inform enhanced future healthcare. Methods: Conducted in accordance with World Health Organization guidelines, multiple databases were searched with a search strategy developed using Boolean operators. Studies were assessed against predetermined inclusion/exclusion criteria, with included studies published in English, with no date/geographical limitations applied and relevant to the research question. Drawing upon Braun and Clarke, collected data were analyzed using a thematic analysis approach. Results: Twelve studies were identified, with findings highlighting significant healthcare barriers for TGDN people AFAB with endometriosis, including delayed diagnosis, limited provider knowledge, and gender dysphoria linked to gynecological care. Studies highlighted a lack of awareness among healthcare providers, contributing to inadequate support. Conclusions: This RSLR provides timely insights into current treatment approaches, barriers to care, and potential strategies to improve gender-affirming and holistic healthcare for TGDN people AFAB experiencing endometriosis and related pelvic pain. Addressing systemic barriers through further research and future interventions may inform improved diagnosis, treatment, and access to care, creating a more supportive and gender-affirming healthcare environment for this underserved population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.